Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion

Frontiers in Immunology(2021)10.3389/fimmu.2021.739037Source: DataRank Database

Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.19)OA: goldTopics (76)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Katharina Röltgen ORCID,Bryan Stevens ORCID,Suchitra Pandey ORCID,Malaya K. Sahoo ORCID,Lorna Tolentino ORCID

Live enrichment

PubMed:34594341 PMC:PMC8477649 OpenAlex:https://openalex.org/W3199775801

NIAID NIH HHS

Grant: R01 AI127877

NCI NIH HHS

Grant: U54 CA260517

NIAID NIH HHS

Grant: R01 AI130398

National Institutes of Health

Grant: 1R01AI130398-01

Effects of aging on primary and secondary vaccine responses in a 15-year longitudinal cohort

National Institutes of Health

Grant: 5R01AI127877-05

Storage and recall of human B cell memory of influenza over tissues and time

National Institutes of Health

Grant: 3U54CA260517-02S2

Mechanisms and Duration of Immunity to SARS-CoV-2

FWCI

0.19

Citation Percentile

0.5%

Citation Trend

2022

2024

2025

goldLicense: cc-by

journalhttps://doi.org/10.3389/fimmu.2021.739037

publisherhttps://doi.org/10.3389/fimmu.2021.739037

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.739037/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34594341

repositoryhttp://europepmc.org/pmc/articles/PMC8477649

Fields of Study

SARS-CoV-2 and COVID-19 ResearchBlood groups and transfusionCOVID-19 Clinical Research Studies0301 basic medicine03 medical and health sciencesAdultAntibodies, NeutralizingAntibodies, ViralAntigens, ViralBlood DonorsCOVID-19ConvalescenceFemaleHumansImmunization, PassiveKineticsMaleMiddle AgedOutpatientsRNA, ViralSARS-CoV-2SeroconversionCOVID-19 Serotherapy

MeSH Terms

SeroconversionCOVID-19SARS-CoV-2COVID-19 SerotherapyAdultAntibodies, ViralAntigens, ViralBlood DonorsConvalescenceFemaleHumansImmunization, PassiveKineticsMaleMiddle AgedOutpatientsRNA, ViralAntibodies, Neutralizing

Keywords

ConvalescenceMedicineTiterAntibodySeroconversionConvalescent plasmaVirologyCoronavirus disease 2019 (COVID-19)ImmunologyAntibody titerPandemicDiseaseInternal medicineInfectious disease (medical specialty)Humoral immune responseAntiviral AntibodiesCovid-19Sars-cov-2Convalescent Plasma For Covid-19 TherapyAdultMaleBlood DonorsAntibodies, ViralOutpatientsHumansAntigens, ViralCOVID-19 SerotherapyImmunization, PassiveRC581-607Middle AgedAntibodies, NeutralizingKineticsRNA, ViralFemaleImmunologic diseases. Allergy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being